Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Friday, January 30, 2015 An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. read more

Originally posted here:
Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise

Leave a Reply